glossary of Abbreviations, Acronyms, and Terminology
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
| Term | Definition |
| 1572 | Statement of Investigator (Form FDA 1572) |
| AACR | American Association for Cancer Research |
| ABTC | Adult Brain Tumor Consortium is a multi-institutional consortium created from the consolidation of two previous, separate NCI-funded consortia: New Approaches to Brain Tumor Therapy (NABTT) and North American Brain Tumor Consortium (NABTC). |
| ACC | Adenoid cystic carcinomas are tumors that most commonly originate in the salivary glands. |
| ACCRU | Academic and Community Cancer Research United is a clinical research group based at the Mayo Clinic Cancer Center in Rochester, Minnesota. ACCRU includes a network of more than 50 academic and community-based cancer treatment clinics and hospitals in the United States and Canada. ACCRU, formerly known as the Mayo Clinic Cancer Research Consortium (MCCRC), was established in 2004 to conduct pharmaceutical industry-sponsored clinical trials to improve cancer treatment. The name was changed to ACCRU in late 2011, coinciding with the formation of the Alliance for Clinical Trials in Oncology. |
| ACOSOG | American College of Surgeons Oncology Group, see Alliance. |
| ACR | American College of Radiology |
| ACRIN | American College of Radiology Imaging Network, see ECOG-ACRIN. |
| ACRP | Association of Clinical Research Professionals was founded in 1976 to address the educational and networking needs of research nurses and others who support the work of clinical investigations. |
| ACS | American Cancer Society |
| ACS CRP | American College of Surgeons Clinical Research Program is one of the five Alliance programs. ACS CRP works to reduce the impact of cancer by validating and disseminating strategies for its prevention and treatment. |
| AdEERS | Adverse Event Expedited Reporting System is a retired NCI web-based system for submitting expedited reports for serious and/or unexpected events. |
| AE | Adverse Event |
| AIS | Audit Information System |
| Alliance | Alliance for Clinical Trials in Oncology is one of the five U.S. network groups of the NCI National Clinical Trials Network (NCTN) Program. Alliance formed from the merger of American College of Surgeons Oncology Group (ACOSOG), Cancer and Leukemia Group B (CALGB), and North Central Cancer Treatment Group (NCCTG). |
| AML | Acute myelogenous leukemia |
| ANFU | Acceptable needs follow-up |
| ASCII | American Standard Code for Information Interchange |
| ASCO | American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. Nearly 30,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. |
| ASH | American Society of Hematology is a professional society concerned with the causes and treatments of blood disorders. The mission of ASH is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology. |
| ASTRO | American Society for Radiation Oncology |
| Term | Definition |
| BC | Breast cancer |
| BioMS | Biospecimen Management System (BioMS) is an Alliance web-based application for logging and tracking shipment of patient biospecimens collected from any Alliance or legacy ACOSOG, CALGB, or NCCTG trial. It serves a similar function as the previous CALGB specimen tracking system (STS). BioMS provides access to a comprehensive inventory of all specimens collected across all Alliance group biorepositories. BioMS training materials, user manuals and FAQs are available on the BioMS Help Site. |
| BIQSFP | Biomarker, Imaging and Quality of Life Studies Funding Program |
| BLA | Biologic License Application |
| BSA | Body surface area |
| Term | Definition |
| caAERS | Cancer Adverse Event Reporting System |
| caBIG | Cancer Biomedical Informatics Grid is an NCI initiative that is maintained by the Center for Biomedical Informatics and Information Technology (CBIIT). Launched in 2004, caBIG is an open source information network. Its mission is to enable secure data exchange throughout the cancer community. |
| caDSR | Cancer Data Standards Registry and Repository is a database and set of APIs and tools to create, curate, and implement use of common data elements (CDEs) on case report forms (CRFs) in the cancer research community. These CDEs are developed by the NCI CBIITT and caBIG. |
| CALGB | Cancer and Leukemia Group B, see Alliance |
| CAO | Chief administrative officer |
| CAP | College of American Pathologists |
| CAPA | Corrective and Preventive Action |
| CAT | Computer Axial Tomography |
| CBCTR | Cooperative Breast Cancer Tissue Resource Database provides researchers with access to approximately 8,000 cases of formalin-fixed, paraffin-embedded primary breast cancer specimens, with associated clinical data. The collection is particularly well-suited for validation studies of diagnostic and prognostic markers. Funded by the NCI. |
| CC | Colon cancer |
| CCOP | Community Clinical Oncology Program is a network for conducting cancer prevention and treatment clinical trials by community physicians. This network connects academic centers (Research Bases who design and conduct the trials) with community physicians (CCOP, MB-CCOP who accrue patients to those trials), see NCORP. |
| CCP | Cancer Control Program is one of the five Alliance programs. CCP conducts innovative scientific studies, including interventional, methodological, and health policy research, to help reduce the incidence, morbidity and mortality of cancer in broad populations. |
| CCRA | Certified Clinical Research Associate. Certification issued by ACRP. |
| CCRC | Certified Clinical Research Coordinator. Certification issued by ACRP. |
| CCRP | Certified Clinical Research Professional. Certification of coordinators, monitors, and other research professionals issued by SoCRA. |
| CDASH | Clinical Data Acquisition Standards Harmonization is a content standard for the data elements that should be captured on a CRF. |
| CDC | Centers for Disease Control and Prevention is a federal agency under the DHHS charged with protecting public health and safety. |
| CDEs | Common data elements are standardized terms for the collection and exchange of data. |
| CDISC | Clinical Data Interchange Standards Consortium |
| CEU | Continuing Education Unit |
| CF | Consent form |
| CFO | Chief financial officer |
| CFR | Code of Federal Regulations; usually cited by title and part. (Example: 21 CFR 211 is Title 21, Part 211.) |
| CHTN | Cooperative Human Tissue Network is an NCI-funded resource that provides normal, benign, pre-cancerous and cancerous human tissue to the scientific community for basic and developmental studies in many areas of cancer research. |
| CIRB | Central Institutional Review Board is a project sponsored by the NCI to facilitate and streamline the local IRB review for national multi-center cancer treatment trials. |
| CLIA | Clinical Laboratory Improvement Amendments |
| CLL | Chronic lymphocytic leukemia |
| CME | Continuing Medical Education |
| CNS | Central nervous system |
| CoC | Commission on Cancer was established by the American College of Surgeons (ACoS). |
| COG | Children's Oncology Group is one of the five U.S. network groups of the NCI National Clinical Trials Network (NCTN) Program. This group was formed in 2000 as a result of the merger of four groups: the Children's Cancer Study Group (CCG), Pediatric Oncology Group (POG), Intergroup Rhabdomyosarcoma Study Group (IRS), and the National Wilms Tumor Study Group (NWTS). |
| COI | Conflict of Interest |
| CoP | Community of Practice |
| COPRTRG | Community Oncology and Prevention Trials Research Group |
| CP3R | Cancer Program Practice Profile Reports are released by the Commission on Cancer (CoC). |
| CPOP | Central Protocol Operations Program is one of the five Alliance programs. CPOP oversees the development, maintenance and distribution of all study protocols that are generated by Alliance scientific committees. |
| CR | Complete Response |
| CRA | Clinical Research Associate, see also CCRA. |
| CRADA | Cooperative Research and Development Agreement |
| CRC | Clinical Research Coordinator, see also CCRC. |
| CRF | Case Report Form |
| CRO | Clinical research organization |
| CRP | Clinical Research Professional; also the name of an Alliance committee for all CRPs involved in data collection and research (e.g., CRAs, data managers/data coordinators, oncology nurses) |
| CSA | Clinical Supply Agreement |
| CSF | Cerebrospinal fluid |
| CT | Computed Tomography |
| CTA | Clinical Trial Agreement |
| CTC | Common Toxicity Criteria is the precursor of what is today named the Common Terminology Criteria for Adverse Events (CTCAE). The original CTC was developed by the Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI) in 1983 to aid in the documentation and analysis of adverse effects of chemotherapy. CTC, like CTCAE, included terms and a severity grading scale with descriptions of the allowed grades of each term. |
| CTCAE | Common Terminology Criteria for Adverse Events is a list of adverse event (AE) terms commonly encountered in oncology. Each AE term is defined and accompanied by a grading scale that indicates the severity of the AE. In CTCAE v4.0, the AE terms are organized by the System Organ Classes (SOCs) defined by the Medical Dictionary for Regulatory Activities (MedDRA). CTCAE has been developed from the earlier vocabulary known as CTC (Common Toxicity Criteria). |
| CTEP | Cancer Therapy Evaluation Program is a program sponsored by the NCI, CTEP funds an extensive national program of cancer research and sponsors clinical trials to evaluate new anti-cancer agents, with a particular emphasis on translational research to elucidate molecular targets and mechanisms of drug effects. |
| CTEP-AERS | CTEP Adverse Event Reporting System |
| CTEP-IAM | Cancer Therapy Evaluation Program (CTEP) Identity and Access Management (IAM) is an application of the NCI that provides user accounts and access to Associates and Investigators participating in NCI-sponsored clinical trials. A CTEP-IAM user account is required to access the members’ area of the Alliance website, as well as CTSU, the Oncology Patient Enrollment Network (OPEN), and CTEP functions (e.g., AdEERS). |
| CTMB | Clinical Trials Monitoring Branch |
| CTMS | Clinical Trial Management System |
| CTRP | Clinical Trials Reporting Program is a comprehensive database established by the NCI to collect regularly updated information, including accrual, on all NCI-supported clinical trials. This database of the entire NCI portfolio helps identify gaps in clinical research and duplicative studies, facilitates effective clinical trial prioritization, and enhances patient accrual to trials by making physicians aware of relevant opportunities for participation in clinical trials. |
| CTSU | Clinical Trials Support Unit is a project sponsored by the NCI for the support of a national network of physicians to participate in NCI-sponsored Phase III cancer treatment trials. The majority of these trials are sponsored by NCTN adult groups. |
| CV | Curriculum Vitae |
| Term | Definition |
| DARF | Drug Accountability Record Form |
| dbGaP | Database of Genotypes and Phenotypes |
| DCP | Division of Cancer Prevention is a division of NCI dedicated to advancing biomedical science, strengthening preventive medicine, and improving public health. |
| DCTD | Division of Cancer Treatment and Diagnosis |
| DHHS | Department of Health and Human Services is the United States government's principal agency for protecting the health of all Americans and providing essential human services, especially for those who are least able to help themselves. The NIH is an operating division of DHHS. Also referred to as HHS. |
| DLT | Dose-limiting toxicity |
| DNA | Deoxyribonucleic acid |
| DSM | Diagnostic and Statistical Manual (of the American Psychiatric Association) |
| DSMB | Data Safety Monitoring Board of the Alliance formally monitors phase 3 and randomized phase 2 trials. The DSMB addresses issues of research participant protection and makes recommendations regarding the continuation, termination, or modification of studies. |
| Term | Definition |
| ECG | Electrocardiogram |
| ECOG | Eastern Cooperative Group. See ECOG-ACRIN. |
| ECOG-ACRIN | ECOG-ACRIN Cancer Research Group is one of the five U.S. network groups of the NCI National Clinical Trials Network (NCTN) Program. ECOG-ACRIN formed from the merger of the Eastern Cooperative Oncology Group (ECOG) and the American College of Radiology Imaging Network (ACRIN). |
| eCRF | Electronic Case Report Form |
| EDC | Electronic Data Capture |
| EORTC | European Organisation for Research and Treatment of Cancer conducts, develops, coordinates, and stimulates laboratory and clinical research in Europe to improve the management of cancer and related problems by increasing survival and quality of life. |
| EU | European Union |
| Term | Definition |
| FACT | Functional Assessment of Cancer Treatment |
| FCOI | Financial conflict of interest |
| FDA | Food and Drug Administration is an agency within the U.S. Department of Health and Human Services. Consists of eight centers/offices designed to ensure the safety and effectiveness of all drugs, biological products (including blood, vaccines and tissues for transplantation), medical devices, and other services. |
| FDG-PET | Fluorodeoxyglucose PET |
| FFPE | Formalin-Fixed, Paraffin-Embedded (tissue) |
| FWA | Federalwide Assurance |
| Term | Definition |
| GBC | Group Banking Committee |
| GAO | U.S. Government Accountability Office |
| GCP | Good Clinical Practice are standards that provide assurance that the data and reported results for clinical trials are credible and accurate, and that the rights, integrity, and confidentiality of trial subjects are protected. |
| GI | Gastro-intestinal |
| GOG | Gynecology Oncology Group, see NRG. |
| GU | Genitourinary |
| GWAS | Genome-wide association studies (GWAS) are used to identify common genetic factors that influence health and disease. |
| Term | Definition |
| HEME | Alliance Hematologic Malignancy Biorepository (HEME), previously known as CALGB Leukemia Tissue Bank, is located at The Ohio State University. |
| HHS | Department of Health and Human Services |
| HIPPA | Health Insurance Portability and Accountability Act |
| HITECH | Health Information Technology for Economic and Clinical Health |
| HMO | Health Maintenance Organization: A type of managed care organization (MCO) that provides a form of health care coverage in the United States. |
| Term | Definition |
| IAM | Identity and Access Management username and passcode issued by the National Cancer Institute (NCI) Cancer Therapy Evaluation Program (CTEP); Alliance members must have IAM username and passcodes to access member-specific information on the Alliance website. |
| IB | Investigator's brochure |
| IBCSG | International Breast Cancer Surgery Group |
| ICC | Informed Consent Content |
| ICD9 | International Classification of Diseases; also see MedDRA |
| ICH | International Conference of Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use |
| ID | Identification |
| IDE | Investigational Device Exemption |
| IND | Investigational new drug; also Investigational New Drug Application. |
| IOM | Institute of Medicine |
| IPEC | Institutional Performance Evaluation Committee is an administrative committee under the Alliance Office of the Group Chair. |
| IRB | Institutional Review Board |
| IS | Information Systems |
| IS | International System of Units; may also be referred to as SI (Systeme Internationale) |
| ISU | Information Systems Unit |
| IT | Information Technology |
| Term | Definition |
| JCAHO | Joint Commission on Accreditation of Healthcare Organizations |
| Term | Definition |
| LAP | Lead Academic Participating (LAP) sites is one of six components of the National Clinical Trials Network (NCTN) program. The Network LAP sites will provide scientific leadership in development and conduct of clinical trials in association with one or more adult Network Groups as well as substantial accrual to clinical trials conducted across the entire NCTN. |
| LCTB | Alliance Lung Cancer Tissue Bank (LCTB) is located at Brigham and Women's Hospital. |
| LOA | Letter of Agreement |
| LOI | Letter of Intent |
| LTB | CALGB Leukemia Tissue Bank, see HEME. |
| Term | Definition |
| MAYO | Alliance Biorepository at Mayo Clinic (MAYO) is a repository for biospecimens associated with solid tumor studies, with a particular focus on neuro-oncology. |
| MBC | Metastatic breast cancer |
| MDS | Myelodysplastic syndrome |
| MedDRA | Medical Dictionary for Regulatory Activities is the current standard medical terminology superseding terminology in ICD9, IMT, and others) |
| MRI | Magnetic resonance imaging |
| MTD | Maximum Tolerated Dose OR Maximum Tolerable Dose |
| Term | Definition |
| NCCCP | NCI Community Cancer Centers Program, see NCORP. |
| NCCTG | North Central Cancer Treatment Group, see Alliance. |
| NCDB | National Cancer Data Base |
| NCI | National Cancer Institute is a component of the National Institutes of Health (NIH) and is the federal government's principal agency for cancer research and training. the NCI provides funding and oversight for the cooperative groups. |
| NCIC-CTG | National Cancer Institute of Canada - Clinical Trials Group: The only adult cooperative oncology group based in Canada that has a national membership and is committed to assessing all modalities of therapy across the spectrum of different types of cancer. The NCIC Clinical Trials Group is supported by a core grant received from the Canadian Cancer Society Research Institute. |
| NCORP | NCI Community Oncology Research Program (NCORP) is a new program expanding upon the success of the Community Clinical Oncology Program (CCOP) Network (including its Minority-Based CCOPs), adding elements of the NCI Community Cancer Centers Program (NCCCP), and creating a network for cancer care delivery research. Both the CCOP Network and NCCCP are being replaced by this new program. |
| NCTN | National Clinical Trials Network (NCTN) Program is the National Cancer Institute's consolidated and integrated transformation of the previous NCI-sponsored Clinical Trials Cooperative Group Program. There are five U.S. network groups: Alliance, COG, ECOG-ACRIN, NRG, and SWOG. |
| NCVHS | National Committee on Vital and Health Statistics is a statutory public advisory body to the Secretary of Health and Human Services in the area of health data and statistics. |
| NDA | New Drug Application |
| NIH | National Institutes of Health is the steward of medical and behavioral research for the United States. It is an agency under the U.S. Department of Health and Human Services. The NCI is an institute of the NIH. |
| NMDP | National Marrow Donor Program is a nonprofit organization dedicated to creating an opportunity for all patients to receive the bone marrow or umbilical cord blood transplant they need, when they need it. |
| NRG | NRG Oncology is one of the five U.S. network groups of the NCI National Clinical Trials Network (NCTN) Program. NRG formed from the merger of National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG) |
| NSABP | National Surgical Adjuvant Breast and Bowel Project, see NRG |
| Term | Definition |
| OAOP | Online Agent Order Processing is an application, deployed by CTEP Pharmaceutical Management Branch (PMB), that provides online ordering of investigational agents. |
| OCR | Office for Civil Rights promotes and ensures that people have equal access to and opportunity to participate in and receive services in all Department of Health and Human Services (DHHS) programs without facing unlawful discrimination. |
| OCR | Optical character recognition: The electronic identification and digital encoding of printed or handwritten characters by means of an optical scanner and specialized software; also the technology used in this process. |
| ODM | Operational Data Modeling |
| OEWG | Operational Efficiency Working Group was established to advise the National Cancer Institute (NCI) on strategies to "Identify the institutional barriers that prolong the time from concept approval to accrual of the first patient, and develop solutions for overcoming these barriers." |
| OHRP | Office for Human Research Protections provides leadership in the protection of the rights, welfare, and wellbeing of subjects involved in research conducted or supported by the U.S. Department of Health and Human Services (HHS). |
| OMH | Office of Minority Health was created by the U.S. Department of Health and Human Services. Its website contains information on a variety of subjects that affect the health of racial and ethnic populations, including cancer. |
| ONS | Oncology Nursing Society |
| OPEN | Oncology Patient Enrollment Network is a web-based registration system for patient enrollments onto NCI-sponsored Cooperative Group clinical trials. The system is integrated with the CTSU Enterprise System for regulatory and roster data, and with each of the Cooperative Groups' registration/randomization systems for patient registration/ randomization. OPEN provides the ability to enroll patients on a 24/7 basis. |
| ORI | Office of Research Integrity oversees and directs Public Health Service (PHS) research integrity activities on behalf of the Secretary of Health and Human Services with the exception of the regulatory research integrity activities of the Food and Drug Administration. |
| OS | Overall survival |
| OSHA | Occupational Safety & Health Administration is an agency of the United States Department of Labor. Its mission is to prevent work-related injuries, illnesses, and occupational fatality by issuing and enforcing standards for workplace safety and health. It was also established to create a better workplace for all workers and to ensure the safety of everyone by making and enforcing certain standards that are needed to protect the people. |
| OTC | Over-the-counter |
| OSTP | Office of Science and Technology Policy |
| OSU | Alliance Biorepository at The Ohio State University (OSU) is a repository for biospecimens associated with solid tumor studies as well as lymphoma studies. |
| Term | Definition |
| PATS | CTEP Enterprise Protocol Authorization and Tracking System |
| PCO | CALGB Pathology Coordinating Office, see OSU |
| PCPA | Per-Case Payment Application is an application used by the Alliance financial department to manage institutional and financial information associated with Payment Programs. |
| Portable Document Format | |
| PDQ | Physicians' Data Query |
| PDR | Physicians' Desk Reference |
| PET | Positron emission tomography |
| PFS | Progression-free survival |
| PFT | Pulmonary function test |
| PHI | Protected Health Information |
| PI | Principal investigator |
| PIO | Protocol Information Office supports CTEP by collecting, processing, tracking and monitoring all protocol-related information between CTEP and its extramural collaborators as well as other CTEP and NCI programs. Note: Not to be confused with Alliance Central Protocol Operations Program (CPOP) Protocol Office, the Alliance unit responsible for developing and amending Alliance protocols. |
| PK | Pharmacokinetics |
| PMB | Pharmaceutical Management Branch provides pharmaceutical support for clinical trials sponsored by the National Cancer Institute's (NCI) Cancer Therapy Evaluation Program (CTEP). |
| PPI | Patient Package Insert |
| PPP | Pharmacogenomics and Population Pharmacology (PPP) Committee is part of the Alliance Translational Research Program (TRP). |
| PR | Partial Response |
| PR | Pulse rate |
| PRO | Patient reported outcomes |
| PS | Performance status |
| PSA | prostate specific antigen |
| PSR | Protocol Specific Requirements |
| Term | Definition |
| Rave | Rave is third-party application for electronically capturing, managing and reporting clinical research data. The NCI selected this application as the standard electronic data capture system for the cooperative groups. |
| RCC | Renal cell carcinoma |
| RDE | Remote Data Entry |
| RDTS | Regulatory Data Transfer System |
| RECIST | Response Evaluation Criteria In Solid Tumors is a set of published rules that define when cancer patients improve or worsen during treatments. The first version of the criteria were published in 2000 by an international collaboration including the European Organisation for Research and Treatment of Cancer (EORTC), National Cancer Institute of the United States, and the National Cancer Institute of Canada Clinical Trials Group. In 2009, a revised set of criteria was released as RECIST v1.1. (Important Note: Refer to the protocol to ensure that you are using the correct criteria.) |
| RFA | Radiofrequency ablation |
| RNA | Ribonucleic acid |
| RRA | Request for Rapid Amendment |
| RSS | Regulatory Support System is designed to track regulatory compliance in an effort to reduce the administrative and regulatory burden on the NCTN groups. Located at the CTSU Regulatory Office, it contains regulatory documents for all adult NCI-sponsored NCTN clinical trials except prevention trials. |
| RT | Radiologic Technology |
| RT | Radiotherapy |
| RTOG | Radiation Therapy Oncology Group, see NRG Oncology |
| RTP | RSS Transaction Processor |
| RUMS | Roster Update Management System |
| Term | Definition |
| SaaS | Software-as-a-Service |
| SBRT | Stereotactic body radiation therapy |
| SAE | Serious adverse event |
| SAS | Statistical Analysis System is a commonly used statistical analysis package. |
| SCT | Society for Clinical Trials |
| SD | Standard deviation |
| SDC | Statistics and Data Management Program is one of the five Alliance programs. SDC, also known as the Statistics and Data Center, supports the activities of the Alliance by achieving the highest standards for the conduct of clinical trials, including study design, statistical methodology, data management, protection of patients and their data, and regulatory compliance. |
| SEI | Sensitive Electronic Information |
| SIG | Special Interest Group |
| SIPs | Surgery Non-Intrinsic Protocols are protocols that include surgical procedures or decision-making in the process of the clinical study but that are not the main focus of the study; these protocols may be initiated in non-surgery committees. |
| SMU | Systems Management Unit |
| SNO | Society for Neuro-Oncology is a multidisciplinary organization dedicated to promoting advances in neuro-oncology through research and education. |
| SoCRA | Society for Clinical Research Associates |
| SOP | Standard operating procedure |
| SQA | Society of Quality Assurance |
| SQA | Surgical Quality Assurance |
| SQAC | Surgical Quality Assurance Committee |
| SSO | Single sign-on |
| STO | Society for Translational Oncology |
| STS | Specimen Tracking System, see BioMS |
| SPOREs | Specialized Programs of Research Excellence is an NCI funding program that promotes collaborative, interdisciplinary translational cancer research. |
| SWOG | SWOG, formerly known as the Southwest Oncology Group, is one of the five U.S. network groups of the NCI National Clinical Trials Network (NCTN) Program. |
| Term | Definition |
| TBPT | Tissue Banking Pathology Tools is a caBIG workspace. |
| TPS | Tissue Procurement Service is part of the Division of Human Tissue Resource Network in the Department of Pathology at The Ohio State University. TPS serves as a resource of remnant human tissue. This service specializes in the procurement, preservation and distribution of human tissues for research of investigators at The Ohio State University and nationwide. |
| TRP | Translational Research Program is one of the five Alliance programs. TRP focuses on molecularly driven oncology, ensuring optimal integration of translational endpoints into Alliance trials and maximizing the scientific productivity resulting from pre-existing and developing Alliance tissue resources. |
| Term | Definition |
| U10 | Cooperative Multicenter Reproductive Medicine Network (U10) is one of the National Institutes of Health funding programs for medical research. |
| UAT | User acceptance testing |
| UC | Urothelial cancer |
| Term | Definition |
| VA | Veterans Administration; U.S. Department of Veterans Affairs |
| VATS | Video assisted thoracic surgery |
| VEGF | Vascular endothelial growth factor |
| VPN | Virtual Private Network |
| Term | Definition |
| WHO | World Health Organization |
| WUSTL | Alliance Biorepository at Washington University (WUSTL) is a repository for biospecimens associated with adjuvant and neoadjuvant trials, and the use of biospecimens for integral and integrated genomics-based biomarker studies. |
| W-9 | Request for Taxpayer Identification Number and Certification (Form W-9) |
